Navigation Links
Lymphoma drug used to treat skin disorders
Date:12/14/2007

Dayton, OH December 14, 2007 A new review article from the journal Dermatologic Therapy reveals that rituximab, a drug used to treat lymphoma, is now becoming used by dermatologists to treat various dangerous skin diseases.

Originally developed as the standard therapy in treating aggressive lymphomas, the drug rituximab is showing increased non-cancer use. The study reviewed the off-label uses of rituximab in dermatology and found that it successfully treated patients with various kinds of blistering skin disease, including pemphigus vulgaris, dermatomyositis, and paraneoplastic pemphigus.

Newer, safer treatments are being studied for serious dermatologic disorders, and rituximabs efficacy has been shown in a variety of dangerous skin problems. As case reports and randomized trials explore the utility of rituximab, the authors note, the indications for rituximab will continue to be defined.


'/>"/>

Contact: Amy Molnar
medicalnews@bos.blackwellpublishing.net
201-748-8844
Blackwell Publishing Ltd.
Source:Eurekalert

Page: 1

Related medicine news :

1. The Leukemia & Lymphoma Society Hosts Workshop On Weighing Treatment Options For Chronic Myelogenous Leukemia
2. The Leukemia & Lymphoma Society Provides Patients with the Latest Information on Myeloma
3. Cell Therapeutics, Inc. (CTI) Plans to Submit Supplemental Biologics License Application (sBLA) for ZEVALIN(R) Consolidation of First Remission in Advanced Stage Follicular Lymphoma in 2008
4. January 1 Looms Large for Lymphoma Patients
5. Micromet and MedImmune to Present New Clinical Data for Anti-CD19 BiTE(R) Antibody at American Society of Hematology Annual Meeting Showing Objective Clinical Responses in Relapsed Non-Hodgkins Lymphoma Patients
6. Possible Cure for Rare Lymphoma Reported
7. Pharmion and Methylgene Report Favorable Results for Phase 2 MGCD0103 Single- Agent Studies in Relapsed or Refractory Lymphomas at the 49th American Society of Hematology (ASH) Meeting
8. Gentler chemotherapy before stem cell transplant causes long-term remission of follicular lymphoma
9. Genmab Initiates Ofatumumab Phase II Study in Diffuse Large B-Cell Lymphoma
10. Using coxibs and NSAIDs to treat osteoarthritis
11. New treatment effective in counteracting cocaine-induced symptoms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/20/2017)... Valencia, Calif. (PRWEB) , ... July 19, 2017 , ... ... has acquired the Minnesota based Health IT business unit of Constellation Inc., a move ... an already established base of operations in St. Louis, the acquisition is expected to ...
(Date:7/20/2017)... California (PRWEB) , ... July 19, 2017 , ... A ... that most successful weight loss surgery patients who had received a body contouring procedure ... health and beauty clinic Beverly Hills Physicians (BHP), which provides both types of procedures, ...
(Date:7/20/2017)... ... ... “Lucky the Buffalo and Her Adventures”: a collection of heartwarming children’s stories. “Lucky the ... Bieniek Jr. was born in Toledo, Ohio. He attended Woodward High School. He ... married to a brilliant woman with a caring heart named Tiina, who is a hospice ...
(Date:7/18/2017)... ... July 18, 2017 , ... ClinicalTrials.gov and the ... You Need to Consider?, **An FDAnews Webinar**, Aug. 2, 2017 — 1:30 p.m. ... “Final Rule for Clinical Trials Registration and Results Information,” is a head-scratcher. After ...
(Date:7/18/2017)... ... July 18, 2017 , ... An inventor from Anacortes, ... "Due to menopause, I have frequent hot flashes, and I suffer from anxiety and ... way to keep cool while out and about." INSTA-FAN meets that need. , This ...
Breaking Medicine News(10 mins):
(Date:7/5/2017)... MANCHESTER, England , July 5, 2017 ... the perfect answer as physics and manufacturing combine to progress ... the thyroid, existing SPECT systems are unable to accurately quantify ... consequence, only limited information regarding the success of this radiotherapy ... ...
(Date:6/30/2017)... Md. , June 30, 2017 In ... since the start of May, at least ten diagnostic ... include private investments, public offerings and a loan facility.  ... million to almost $80 million.  Kalorama Information provides a ... of its Diagnostics Knowledge Center. ...
(Date:6/20/2017)... ROTTERDAM, Netherlands and LAGUNA HILLS, ... announced the presentation of new data that validate the ... to risk stratify patients with multiple myeloma (MM). In ... of the European Hematology Association (EHA) in ... prognostic value of MMprofiler for identifying high-risk elderly patients. ...
Breaking Medicine Technology: